Quebec Lung Cancer Screening PLUS Trial
COPD | Coronary Artery CalcificationDoes an educational intervention for untreated COPD and cardiovascular disease which is integrated in an existing lung cancer screening program improve guideline concordant medication adherence at 12 months
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
55 to 74
Participation Criteria
Inclusion Criteria:
* Patient screened for lung cancer as part of the Quebec Lung Cancer Demonstration project by low dose CT scan of the chest.
* Cardiovascular aim: mild to severe CAC identified on low dose CT, not on guideline recommended lipid-lowering therapy.
* COPD aim: diagnosed with COPD, symptomatic (mMRC \>=1 or CAT\>= 10) and untreated, or not on first line guideline recommended therapy for COPD.
Exclusion Criteria:
* Any participant with a high suspicion of lung cancer, defined as Lung-RADS (Lung Imaging Reporting and Data System) 3 or 4, as this is an inopportune time to initiate new medical therapies.
* Cardiovascular aim: Absent CAC, known clinical atherosclerosis, known former heart surgery, Diabetes Mellitus.
* COPD aim: asymptomatic, or already on appropriate first line COPD therapy.
Study Location
McGill University Health Center
McGill University Health CenterMontreal, Quebec
Canada
Contact Study Team
- Study Sponsored By
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Participants Required
- More Information
- Study ID:
NCT05444062